HRP20040623B1 - Method for producing scopine esters - Google Patents

Method for producing scopine esters

Info

Publication number
HRP20040623B1
HRP20040623B1 HRP20040623AA HRP20040623A HRP20040623B1 HR P20040623 B1 HRP20040623 B1 HR P20040623B1 HR P20040623A A HRP20040623A A HR P20040623AA HR P20040623 A HRP20040623 A HR P20040623A HR P20040623 B1 HRP20040623 B1 HR P20040623B1
Authority
HR
Croatia
Prior art keywords
bromine
chlorine
hydroxy
formula
group
Prior art date
Application number
HRP20040623AA
Other languages
English (en)
Croatian (hr)
Inventor
Brandenburg J�rg
Pfrengle Waldemar
Rall Werner
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg.
Publication of HRP20040623A2 publication Critical patent/HRP20040623A2/hr
Publication of HRP20040623B1 publication Critical patent/HRP20040623B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems
HRP20040623AA 2002-01-12 2004-07-09 Method for producing scopine esters HRP20040623B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10200943A DE10200943A1 (de) 2002-01-12 2002-01-12 Verfahren zur Herstellung von Scopinestern
PCT/EP2002/014756 WO2003057694A1 (de) 2002-01-12 2002-12-24 Verfahren zur herstellung von scopinestern

Publications (2)

Publication Number Publication Date
HRP20040623A2 HRP20040623A2 (en) 2005-04-30
HRP20040623B1 true HRP20040623B1 (en) 2012-09-30

Family

ID=7711974

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040623AA HRP20040623B1 (en) 2002-01-12 2004-07-09 Method for producing scopine esters

Country Status (31)

Country Link
US (1) US6747154B2 (xx)
EP (2) EP1972626A3 (xx)
JP (1) JP5134756B2 (xx)
KR (1) KR100929503B1 (xx)
CN (1) CN100406456C (xx)
AT (1) ATE404557T1 (xx)
AU (1) AU2002361218B2 (xx)
BR (1) BR0215493A (xx)
CA (1) CA2471755C (xx)
CO (1) CO5601006A2 (xx)
CY (1) CY1108471T1 (xx)
DE (2) DE10200943A1 (xx)
DK (1) DK1467993T3 (xx)
EA (1) EA007230B1 (xx)
EC (1) ECSP045182A (xx)
ES (1) ES2312655T3 (xx)
HK (1) HK1073847A1 (xx)
HR (1) HRP20040623B1 (xx)
HU (1) HU226665B1 (xx)
IL (2) IL162416A0 (xx)
ME (1) MEP51208A (xx)
MX (1) MXPA04006677A (xx)
NO (1) NO328825B1 (xx)
NZ (1) NZ534339A (xx)
PL (1) PL208132B1 (xx)
PT (1) PT1467993E (xx)
RS (1) RS50771B (xx)
SI (1) SI1467993T1 (xx)
UA (1) UA78753C2 (xx)
WO (1) WO2003057694A1 (xx)
ZA (1) ZA200403852B (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
DE10216427A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum
US20040048887A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040044020A1 (en) * 2002-07-09 2004-03-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20040166065A1 (en) * 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
CA2495275C (en) * 2002-08-14 2012-04-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic agent
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
JP2007500676A (ja) * 2003-07-31 2007-01-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤
EP2067779B9 (de) * 2003-11-03 2013-10-16 Boehringer Ingelheim International GmbH Tiotropiumsalze, Verfahren zu deren Herstellung und Arzneimittelformulierungen diese enthaltend
EP2336127A1 (de) * 2003-11-03 2011-06-22 Boehringer Ingelheim International GmbH Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
DE102004041253A1 (de) 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
WO2006117299A2 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
MX2007015997A (es) * 2005-06-15 2008-03-07 Boehringer Ingelheim Int Procedimiento para preparar nuevas sales de tiotropio, nuevas sales de tiotropio como tales y composiciones farmaceuticas de las mismas.
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
US20070088160A1 (en) * 2005-08-15 2007-04-19 Thomas Krueger Process for the manufacturing of betamimetics
WO2008089852A1 (de) * 2007-01-26 2008-07-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg Neues verfahren zur herstellung von tiotropiumsalzen
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
EP1997819A1 (de) 2007-05-25 2008-12-03 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopinestern
US20110028508A1 (en) * 2008-01-10 2011-02-03 Gemerocs [UK] Limited Novel process for the preparation of scopine esters
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
AU2010280497B2 (en) 2009-08-07 2015-10-22 Generics [Uk] Limited Anhydrate of tiotropium bromide
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
TR201002520A2 (tr) * 2010-04-01 2010-05-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür imalat metodu.
US8957209B2 (en) 2010-04-01 2015-02-17 Mahmut Bilgic Methods for the synthesis of tiotropium bromide
TR201005222A2 (tr) * 2010-04-01 2011-10-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür sentez yöntemi
TR201005221A2 (tr) * 2010-04-01 2012-01-23 Bi̇lgi̇ç Mahmut Geliştirilmiş sentez metodu.
ITRM20110508A1 (it) 2011-09-27 2013-03-28 Lusochimica Spa Processo per la preparazione degli esteri della scopina.
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
CZ304808B6 (cs) 2012-03-16 2014-11-05 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu a jeho nová forma
CZ305012B6 (cs) 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418716A1 (de) * 1989-09-16 1991-03-27 Boehringer Ingelheim Kg Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen
WO1992016528A1 (de) * 1991-03-15 1992-10-01 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540633A1 (de) 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
DE3211185A1 (de) 1982-03-26 1983-09-29 Boehringer Ingelheim KG, 6507 Ingelheim Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung
DE3215493A1 (de) 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
ATE222587T1 (de) * 1994-04-19 2002-09-15 Neurosearch As TROPAN-2-ALDOXIMDERIVATE ALS NEUROTRANSMITTER ßREUPTAKEß INHIBITOREN
DE19515625C2 (de) 1995-04-28 1998-02-19 Boehringer Ingelheim Kg Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern
US6153618A (en) * 1996-10-11 2000-11-28 Chiron Corporation Inhibitors of glycogen synthase 3 kinase
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418716A1 (de) * 1989-09-16 1991-03-27 Boehringer Ingelheim Kg Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen
WO1992016528A1 (de) * 1991-03-15 1992-10-01 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums

Also Published As

Publication number Publication date
EA200400875A1 (ru) 2004-12-30
WO2003057694A1 (de) 2003-07-17
CA2471755A1 (en) 2003-07-17
NO328825B1 (no) 2010-05-25
EP1467993B1 (de) 2008-08-13
HK1073847A1 (en) 2005-10-21
US6747154B2 (en) 2004-06-08
US20030232993A1 (en) 2003-12-18
KR100929503B1 (ko) 2009-12-03
JP2005519890A (ja) 2005-07-07
DK1467993T3 (da) 2008-11-10
CN1610680A (zh) 2005-04-27
HRP20040623A2 (en) 2005-04-30
MXPA04006677A (es) 2004-10-04
KR20040072715A (ko) 2004-08-18
EP1467993A1 (de) 2004-10-20
IL162416A (en) 2010-06-30
NO20043341L (no) 2004-08-11
ZA200403852B (en) 2005-06-22
DE50212650D1 (de) 2008-09-25
CY1108471T1 (el) 2014-04-09
AU2002361218A1 (en) 2003-07-24
ECSP045182A (es) 2004-08-27
CN100406456C (zh) 2008-07-30
NZ534339A (en) 2005-04-29
PL208132B1 (pl) 2011-03-31
IL162416A0 (en) 2005-11-20
HU226665B1 (en) 2009-06-29
ATE404557T1 (de) 2008-08-15
RS50771B (sr) 2010-08-31
PT1467993E (pt) 2008-09-03
MEP51208A (en) 2011-05-10
EP1972626A2 (de) 2008-09-24
BR0215493A (pt) 2004-12-28
JP5134756B2 (ja) 2013-01-30
ES2312655T3 (es) 2009-03-01
HUP0402604A2 (hu) 2005-04-28
HUP0402604A3 (en) 2008-05-28
EP1972626A3 (de) 2008-10-01
CO5601006A2 (es) 2006-01-31
UA78753C2 (en) 2007-04-25
CA2471755C (en) 2011-02-08
RS59404A (xx) 2007-04-10
AU2002361218B2 (en) 2008-04-24
DE10200943A1 (de) 2003-07-24
PL369126A1 (en) 2005-04-18
SI1467993T1 (sl) 2009-02-28
EA007230B1 (ru) 2006-08-25

Similar Documents

Publication Publication Date Title
HRP20040623B1 (en) Method for producing scopine esters
PE20070121A1 (es) 2,4-diamino-pirimidinas como inhibidores de aurora
EP1881051A4 (en) PROCESS FOR MANUFACTURING COKE OF HIGH STOVE
AR031852A1 (es) Compuestos para tratar enfermedad de alzheimer
PE20060598A1 (es) Derivado heterociclo conteniendo nitrogeno como antagonista de quimiocina ccr5
NO20075626L (no) Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes
DE602005007864D1 (de) Modifizierung von erdalkalimetallsilicatfasern
EP1854795A4 (en) SALT OF A PROLIN DERIVATIVE, SOLVAT THEREOF AND METHOD FOR THE PRODUCTION THEREOF
TW200614988A (en) Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
MX347178B (es) Cocristales de l-prolina y acido citrico de (2s,3r,4r,5s,6r)-2-(3- ((5-(4-fluorofenil) tiofen-2-il)metil)-4-metilfenil)-6-(hidroximet il)tetrahidro-2h-piran-3, 4.5-triol.
WO2006031893A3 (en) Fused thiophenes, methods for making fused thiophenes, and uses thereof
TNSN07272A1 (en) Substituted bis aryl and heteroaryl compounds as selective 5ht 2a antagonists
ATE557020T1 (de) Alkyl-3-ä2-(benzoäbüthiophen-5-yl)-ethoxyü- propanoate als intermediate in der herstellung von azetidin-3-ol derivativen
MX2009008421A (es) Proceso para la oxidacion de ciertas sulfiliminas sustituidas a sulfoximinas insecticidas.
GB0600763D0 (en) 6, 7-dihydrobenzimidazo[1,2-C]quininazolin-6-one carboxylic acid, its esters and method of synthesis thereof
TR201106170T1 (tr) Yüksek performansyonlu cam elyaflar için bileşim ve bu bileşimle oluşturulan elyaflar.
NO20070089L (no) DPP-IV inhibitorer
TW200722913A (en) Dye-containing curable composition, color filter and method of producing thereof
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
RS20050719A (xx) Novi difenil-azetidinon sa poboljšanim fiziološkim osobinama postupak za njegovu proizvodnju,lekovi koji sadrže ovo jedinjenje i njihova upotreba
EP1568665A3 (en) An optical glass for precision molding
ATE452135T1 (de) Herstellungsverfahren für silylisocyanurat
SI1688146T1 (sl) Priprava aldesleukina za farmacevtsko uporabo
PE20070080A1 (es) Penemes biciclicos de 6-alquilideno como inhibidores de beta-lactamasas clase d
AR054072A1 (es) 3-amino arilpropil indoles como inhibidores de reabsorcion de monoaminas. procesos de obtencion y composiciones farmaceuticas

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20111219

Year of fee payment: 10

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20121225